Latest news with #GreenhavenRoadCapital
Yahoo
2 days ago
- Business
- Yahoo
Greenhaven Road Capital's Investment Thesis for AST SpaceMobile (ASTS)
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here. In the second quarter, the fund returned approximately +14% net of fees and expenses, bringing the YTD returns to under +1%. YTD, the Russell 2000 has returned -1.8%. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Greenhaven Road Capital highlighted stocks such as AST SpaceMobile, Inc. (NASDAQ:ASTS). Headquartered in Midland, Texas, AST SpaceMobile, Inc. (NASDAQ:ASTS) designs and develops a constellation of BlueBird satellites. The one-month return of AST SpaceMobile, Inc. (NASDAQ:ASTS) was -15.64%, and its shares gained 40.33% of their value over the last 52 weeks. On August 18, 2025, AST SpaceMobile, Inc. (NASDAQ:ASTS) stock closed at $48.16 per share, with a market capitalization of $17.266 billion. Greenhaven Road Capital stated the following regarding AST SpaceMobile, Inc. (NASDAQ:ASTS) in its second quarter 2025 investor letter: "Among the companies in our portfolio, AST SpaceMobile, Inc. (NASDAQ:ASTS) presents the widest range of potential outcomes. AST is developing a space-based cellular broadband network using a constellation of satellites that will communicate directly with unmodified smartphones using the same cellular bands as terrestrial towers. If successful, users will never be out of cellular range. Their network will provide coverage in areas where traditional cell towers cannot reach, enabling users to stream Netflix in the middle of the ocean using their unmodified iPhone. An aerial view of a communications satellite in orbit, beaming its signal down to Earth. AST SpaceMobile, Inc. (NASDAQ:ASTS) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 22 hedge fund portfolios held AST SpaceMobile, Inc. (NASDAQ:ASTS) at the end of the first quarter, which was 22 in the previous quarter. While we acknowledge the potential of AST SpaceMobile, Inc. (NASDAQ:ASTS) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered AST SpaceMobile, Inc. (NASDAQ:ASTS) and shared the list of stocks on euphoria. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Sable Offshore (SOC): Greenhaven Road Capital's High-Expected-Value with Uncertain Timing Investment
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here. In the second quarter, the fund returned approximately +14% net of fees and expenses, bringing the YTD returns to under +1%. YTD, the Russell 2000 has returned -1.8%. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Greenhaven Road Capital highlighted stocks such as Sable Offshore Corp. (NYSE:SOC). Sable Offshore Corp. (NYSE:SOC) is a US-based independent oil and gas company. The one-month return of Sable Offshore Corp. (NYSE:SOC) was -4.57%, and its shares gained 89.72% of their value over the last 52 weeks. On August 18, 2025, Sable Offshore Corp. (NYSE:SOC) stock closed at $28.80 per share, with a market capitalization of $2.866 billion. Greenhaven Road Capital stated the following regarding Sable Offshore Corp. (NYSE:SOC) in its second quarter 2025 investor letter: "One example of what I believe is a high expected value with uncertain timing investment is Sable Offshore Corp. (NYSE:SOC), which I first wrote about in the Q3 2024 letter (link). I think there is a > 90% chance of a +150% outcome in the next year which implies an expected value of +135% (assuming a complete loss in the 10% scenario which I think is extremely conservative). Of course, there is a very wide range of potential outcomes including the loss of capital. A drilling rig in action in the Western Canadian wilderness, showing the companies focus on exploration and production. Sable Offshore Corp. (NYSE:SOC) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 29 hedge fund portfolios held Sable Offshore Corp. (NYSE:SOC) at the end of the first quarter, which was 28 in the previous quarter. While we acknowledge the potential of Sable Offshore Corp. (NYSE:SOC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Sable Offshore Corp. (NYSE:SOC) and shared the list of hot oil stocks to buy. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Does LifeCore (LFCR) Have a High Expected Value?
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here. In the second quarter, the fund returned approximately +14% net of fees and expenses, bringing the YTD returns to under +1%. YTD, the Russell 2000 has returned -1.8%. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Greenhaven Road Capital highlighted stocks such as Lifecore Biomedical, Inc. (NASDAQ:LFCR). Lifecore Biomedical, Inc. (NASDAQ:LFCR) is an integrated contract development and manufacturing organization. The one-month return of Lifecore Biomedical, Inc. (NASDAQ:LFCR) was -0.54%, and its shares gained 30.05% of their value over the last 52 weeks. On August 18, 2025, Lifecore Biomedical, Inc. (NASDAQ:LFCR) stock closed at $7.40 per share, with a market capitalization of $276.818 million. Greenhaven Road Capital stated the following regarding Lifecore Biomedical, Inc. (NASDAQ:LFCR) in its second quarter 2025 investor letter: "Another holding that I believe has a high expected value is Lifecore Biomedical, Inc. (NASDAQ:LFCR), which I have written about extensively. Here is a link to a recent presentation (link) I did for the investing platform SumZero. Kyle and I visited the manufacturing facility in Minnesota during the quarter and spent time with management and the business development team. As a reminder, LifeCore is a contract drug manufacturer which has recently added significant manufacturing capacity. They are operating at approximately 20% of their capacity with 15% EBITDA margins. A village pharmacist fulfilling a patient's medication prescription in a rural area. Lifecore Biomedical, Inc. (NASDAQ:LFCR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 12 hedge fund portfolios held Lifecore Biomedical, Inc. (NASDAQ:LFCR) at the end of the first quarter compared to 10 in the previous quarter. While we acknowledge the potential of Lifecore Biomedical, Inc. (NASDAQ:LFCR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Lifecore Biomedical, Inc. (NASDAQ:LFCR) and shared Laughing Water Capital's views on the company. Greenhaven Road Capital increased its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR) in the previous quarter to nearly 10%. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
2 days ago
- Business
- Yahoo
PAR Technology (PAR): High Expected Value, Uncertain Timing
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here. In the second quarter, the fund returned approximately +14% net of fees and expenses, bringing the YTD returns to under +1%. YTD, the Russell 2000 has returned -1.8%. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Greenhaven Road Capital highlighted stocks such as PAR Technology Corporation (NYSE:PAR). PAR Technology Corporation (NYSE:PAR) offers omnichannel cloud-based hardware and software solutions to the restaurant and retail industries. The one-month return of PAR Technology Corporation (NYSE:PAR) was -25.90%, and its shares lost 1.82% of their value over the last 52 weeks. On August 18, 2025, PAR Technology Corporation (NYSE:PAR) stock closed at $52.25 per share, with a market capitalization of $2.12 billion. Greenhaven Road Capital stated the following regarding PAR Technology Corporation (NYSE:PAR) in its second quarter 2025 investor letter: "PAR Technology Corporation (NYSE:PAR) – PAR is another difficult company to forecast earnings precisely. The company primarily adds new customers through RFP processes, the duration and outcome of which are not known. Even after winning an RFP, the implementation timeline is dictated by the customer. This past quarter saw a rollout implementation slowdown from Burger King, their largest customer, which halted implementation because they are adopting an additional module. This is a very 'good' problem to have – your largest customer slowing down to buy more product. It is also worth noting that Burger King has several additional cross-sale opportunities including Popeye's, Tim Hortons, and Burger King International. Burger King buying more is an excellent data point even if it had a negative impact on last quarter's revenue. An engineer working in a tech lab, surrounded by tools and components. PAR Technology Corporation (NYSE:PAR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 28 hedge fund portfolios held PAR Technology Corporation (NYSE:PAR) at the end of the first quarter compared to 33 in the third quarter. PAR Technology Corporation's (NYSE:PAR) second quarter revenue increased nearly 44% to $112.4 million. While we acknowledge the potential of PAR Technology Corporation (NYSE:PAR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered PAR Technology Corporation (NYSE:PAR) and shared Laughing Water Capital's views on the company in the previous quarter. In its Q1 2025 investor letter, Greenhaven Road Capital highlighted PAR Technology Corporation (NYSE:PAR) as a resilient high growth company. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
2 days ago
- Business
- Yahoo
Cellebrite (CLBT) Fell on Investors' Worry that US Federal Budget Uncertainty Could Delay Purchases
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here. In the second quarter, the fund returned approximately +14% net of fees and expenses, bringing the YTD returns to under +1%. YTD, the Russell 2000 has returned -1.8%. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Greenhaven Road Capital highlighted stocks such as Cellebrite DI Ltd. (NASDAQ:CLBT). Headquartered in Petah Tikva, Israel, Cellebrite DI Ltd. (NASDAQ:CLBT) is a software company that develops solutions for legally sanctioned investigations. The one-month return of Cellebrite DI Ltd. (NASDAQ:CLBT) was 13.32%, and its shares lost 3.69% of their value over the last 52 weeks. On August 18, 2025, Cellebrite DI Ltd. (NASDAQ:CLBT) stock closed at $16.16 per share, with a market capitalization of $3.951 billion. Greenhaven Road Capital stated the following regarding Cellebrite DI Ltd. (NASDAQ:CLBT) in its second quarter 2025 investor letter: "Cellebrite DI Ltd. (NASDAQ:CLBT) - Cellebrite has been our worst performing holding YTD. Investors are concerned that uncertainty around US federal budgets will lead to delayed purchases. Additionally, an acceleration of the business is implied to meet 2025 guidance. Thus, while the company has not cut 2025 guidance yet, there is a real risk that it will. Fortunately, unlike the share price, the business is not falling off a cliff. In Q1, Annual Recurring Revenue (ARR) of $408.0 million was up 23% year-over-year. A female engineer in a datacenter, wearing a headset, monitoring digital data. Cellebrite DI Ltd. (NASDAQ:CLBT) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 30 hedge fund portfolios held Cellebrite DI Ltd. (NASDAQ:CLBT) at the end of the first quarter, which was 34 in the previous quarter. Cellebrite DI Ltd. (NASDAQ:CLBT) reported revenue of $113.3 million in Q2 2025, up 18% from Q2 2024, driven by subscription revenue growth of 21%. While we acknowledge the potential of Cellebrite DI Ltd. (NASDAQ:CLBT) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Cellebrite DI Ltd. (NASDAQ:CLBT) and shared the list of stocks crushing while Wall Street naps. In its Q1 2025 investor letter, Greenhaven Road Capital highlighted Cellebrite DI Ltd. (NASDAQ:CLBT) and shared its views on the company. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
